Shelat Research Group
Advances in automation and miniaturization technologies in the last decade have enabled unprecedented interrogation of biology at multiple scales – the “omics” revolution. For example, structural genomics offers atomic resolution of the interactions between biological macromolecules and ligands; the cellular inventory of RNA transcripts can be explored via microarrays; and high-throughput sequencing can detect genetic variation in populations. A key challenge for the life sciences will be to resolve how best to integrate these disparate streams of information. The Shelat research group employs techniques from computational chemistry and informatics to learn from the wealth of available biological and chemical data, and then, uses the insights gained to guide the development of novel therapeutics.
Lead Discovery Informatics (LDI) Group
The LDI group is tasked with building and maintaining a chemo-centric infrastructure for the Chemical Biology and Therapeutics Department. We work with every CBT group and their external collaborators to ensure that all relevant biological and chemical data is captured, indexed, and made readily available.
Our mission includes the following:
Compound Management (CM) Group
CM serves the critical role of making chemical matter readily available for biological screening. We provide the following services: